Retraction to: Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis (Tumor Biol., (2014), 35, (6011-6020), DOI 10.1007/s13277-014-1796-1);Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 6011-6020

  Li, Fan Fan ^a   Yang, Yang ^a   Wang, Xiao Lei ^a   Hong, Yan Yan ^a   Wang, Nian Fei ^a   Chen, Zhen Dong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

DAPK; Meta analysis; Methylation; Nonsmall cell lung cancer

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE;

ARTICLE; ASIAN; BLOOD SAMPLING; CANCER GROWTH; CANCER RISK; CANCER TISSUE; CAUCASIAN; DNA METHYLATION; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

CARCINOMA, NON-SMALL-CELL LUNG; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC;

EID: 84904723907     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3697-3     Document Type: Erratum

References (35)

1. Takeda K, Hida T, Sato T, Ando M, Seto T, Satouchi M, et al. Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan Thoracic Oncology Group Trial (WJTOG0203). J Clin Oncol. 2010;28(5):753-60.
2. Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10(11):760-74.
3. Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, PapottiM, et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010;8(9):1207-16.
4. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell. 2012;150(6):1121-34.
5. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One. 2008;3(2):e1651.
6. Cebrian A, Taron M, Sala N, Ardanaz E, Chirlaque MD, Larranaga N, et al. Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibility. Clin Transl Oncol. 2014;(in press)
7. Alberg AJ, Wallace K, Silvestri GA, Brock MV. Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol. 2013;177(7):613-6.
8. Carvalho RH, Haberle V, Hou J, van Gent T, Thongjuea S, van Ijcken W, et al. Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics Chromatin. 2012;5(1):9.
9. Zhang CY, Jin YT, Xu HY, Zhang H, Zhang WM, Sun XY, et al. Relationship between promoter methylation of p16, DAPK and RAR beta genes and the clinical data of non-small cell lung cancer. Chin J Med Genetics. 2011;28(1):23-8.
10. de Diego I, Kuper J, Bakalova N, Kursula P, Wilmanns M. Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. Sci Signal. 2010;3(106)):ra6.
11. Bai T, Tanaka T, Yukawa K. Targeted knockdown of death-associated protein kinase expression induces trail-mediated apoptosis in human endometrial adenocarcinoma cells. Int J Oncol. 2010;37(1):203-10.
12. Lin Q, Geng J, Ma K, Yu J, Sun J, Shen Z, et al. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J Cancer Res Clin Oncol. 2009;135(12):1675-84.
13. Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Tamiya S, et al. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum Pathol. 2004;35(10):1266-71. (Pubitemid 39361651)
14. Lin Y, Hupp TR, Stevens C. Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J. 2010;277(1):48-57.
15. Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, et al. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Cancer Lett. 2011;303(1):21-8.
16. De Jong WK, Verpooten GF, Kramer H, Louwagie J, Groen HJ. Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer. Anticancer Res. 2009;29(1):363-9.
17. Arslan S, Dogan T, Koksal B, Yildirim ME, Gumus C, Elagoz S, et al. Tumoral tissue specific promoter hypermethylation of distinct tumor suppressor genes in a case with nonsmall cell lung carcinoma: a case report. Lung India. 2008;25(4):148-51.
18. Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2008;17(3):645-54. (Pubitemid 351469215)
19. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies inmeta-analyses. Eur J Epidemiol. 2010;25(9):603-5.
20. Zintzaras E, Ioannidis JP. Hegesma: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672-3. (Pubitemid 41264106)
21. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676-80. (Pubitemid 43209069)
22. Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, et al. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer. 2007;96(8):1278-83. (Pubitemid 46625083)
23. Chen P, Wei YC, Shen Y. Relationship between non-small cell lung cancer and plasma DAPK gene methylation. Med J Qilu. 2012;27(5):380-2.
24. Kim YT, Lee SH, Sung SW, Kim JH. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Ann Thorac Surg. 2005;79(4):1180-8. discussion -8.
25. Lin Q, Chen LB, Tang YM, Wang J. Combined detection of the serum DAPK gene and p16 gene methylation in patients with on-small cell lung cancer. Chin J Gerontol. 2006;26(10):1304-6.
26. Lu DG, Ji XQ. Detection and significance of DAPK hypermethylation in patients with non-small cell lung cancer. Shandong Med J. 2010;50(9):69-70.
27. Song C, Zhang Y, Jin YT, Yu ZC, Xue SL. Detection and clinical significance of DAPK gene methylation in plasma of non-small cell lung cancer patients. Cancer Res Prev Treatment. 2013;40(8):772-5.
28. Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, et al. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin Cancer Res. 2003;9(8):3034-41. (Pubitemid 36993264)
29. Wang Y, Zhang D, Zheng W, Luo J, Bai Y, Lu Z. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer. 2008;112(6):1325-36. (Pubitemid 351429748)
30. Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, et al. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer. 2007;58(1):131-8. (Pubitemid 47379969)
31. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001;61(1):249-55. (Pubitemid 32095725)
32. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, et al. Dap kinase links the control of apoptosis to metastasis. Nature. 1997;390(6656):180-4. (Pubitemid 27507988)
33. Gade P, Roy SK, Li H, Nallar SC, Kalvakolanu DV. Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol. 2008;28(8):2528-48.
34. Qian J, Wang YL, Lin J, Yao DM, Xu WR, Wu CY. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol. 2009;82(2):119-23.
35. Michie AM, McCaig AM, Nakagawa R, Vukovic M. Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS J. 2010;277(1):74-80.